Logo
P

Prilenia

38 employees

Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Life Science
Health Care

Date founded

2018

Funding rounds raised

Total raised

$63M

from 9 investors over 9 rounds

P

Prilenia raised $43M on November 3, 2021

Investors: Sectoral Asset Management, Amplitude Ventures, Sands Capital Management, Morningside Venture Partners, Forbion and ALS Investment Fund

P

Prilenia raised $63M on June 3, 2020

Investors: Forbion, Morningside Venture Capital 晨兴资本 and Sectoral Asset Management

FAQ